Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan G Casson

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 7, 2010
Obesity is not associated with adverse outcome following surgical resection of oesophageal adenocarcinomaKoroush Madani, Ronghua Zhao, Hyun Ja Lim, et al.
Cancer Epidemiology|August 15, 2009
A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinomaKimberley MacDonald, Geoffrey A Porter, Duane L Guernsey, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 9, 2008
Does previous fundoplication alter the surgical approach to esophageal adenocarcinoma?Alan G Casson, Koroush Madani, Sarika Mann, et al.
International Journal of Cancer|February 3, 2005
Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosisS Jane Darnton, Laura J Hardie, Ronald S Muc, et al.
Molecular Carcinogenesis|May 6, 2009
Regulation of CDX2 expression in esophageal adenocarcinomaNadine Vaninetti, Lara Williams, Laurette Geldenhuys, et al.
Carcinogenesis|October 22, 2009
Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissuesRonghua Zhao, John F DeCoteau, C Ronald Geyer, et al.
Carcinogenesis|May 10, 2005
Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinomaAlan G Casson, Zuoyu Zheng, Susan C Evans, et al.
BMC Molecular Biology|January 25, 2008
Alternative splicing and differential subcellular localization of the rat FGF antisense gene productShuo Cheng Zhang, Kimberley A MacDonald, Mark Baguma-Nibasheka, et al.
Molecular Carcinogenesis|September 13, 2007
Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinomaNadine M Vaninetti, Laurette Geldenhuys, Geoffrey A Porter, et al.
Cancer Letters|December 25, 2004
p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterationsLaura J Hardie, S Jane Darnton, Yvonne L Wallis, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 7, 2010
Obesity is not associated with adverse outcome following surgical resection of oesophageal adenocarcinomaKoroush Madani, Ronghua Zhao, Hyun Ja Lim, et al.
Cancer Epidemiology|August 15, 2009
A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinomaKimberley MacDonald, Geoffrey A Porter, Duane L Guernsey, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 9, 2008
Does previous fundoplication alter the surgical approach to esophageal adenocarcinoma?Alan G Casson, Koroush Madani, Sarika Mann, et al.
International Journal of Cancer|February 3, 2005
Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosisS Jane Darnton, Laura J Hardie, Ronald S Muc, et al.
Molecular Carcinogenesis|May 6, 2009
Regulation of CDX2 expression in esophageal adenocarcinomaNadine Vaninetti, Lara Williams, Laurette Geldenhuys, et al.
Carcinogenesis|October 22, 2009
Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissuesRonghua Zhao, John F DeCoteau, C Ronald Geyer, et al.
Carcinogenesis|May 10, 2005
Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinomaAlan G Casson, Zuoyu Zheng, Susan C Evans, et al.
BMC Molecular Biology|January 25, 2008
Alternative splicing and differential subcellular localization of the rat FGF antisense gene productShuo Cheng Zhang, Kimberley A MacDonald, Mark Baguma-Nibasheka, et al.
Molecular Carcinogenesis|September 13, 2007
Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinomaNadine M Vaninetti, Laurette Geldenhuys, Geoffrey A Porter, et al.
Cancer Letters|December 25, 2004
p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterationsLaura J Hardie, S Jane Darnton, Yvonne L Wallis, et al.
Pageof 6